Potential synergism of natural products in the treatment of cancer

被引:241
作者
Hemalswarya, S [1 ]
Doble, M [1 ]
机构
[1] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India
关键词
chemoprevention; phytochemicals; herb-drug interactions; curcumin; epigallocatechin gallate; quercitin; genistein;
D O I
10.1002/ptr.1841
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Cancer is the second leading cause of death worldwide. There is thus increased interest in alternative treatment modalities that include chemotherapy, hormonal supplements, surgery, radiation therapy, complementary or alterative medicine, used alone or in combination. Therefore patients who are subjected to combination treatments such as hormonal supplements or alternative medicine face considerable risk of drug-drug interactions. The administration of herbal drugs by patients without a physician's prior counseling is increasing globally and there is a possibility of herb-drug interactions too. Herbal drugs or extracts themselves contain a combination of active constituents, which interact within themselves and also between other prescribed pharmaceutical drugs to either enhance (synergize) or decrease (antagonize) the therapeutic effect. This review focuses on a number of reports of herb-drug interactions, their mechanism of action with a special emphasis on dietetic phytochemicals such as quercetin, genistein, curcumin and catechins. All phytochemicals tend to increase the therapeutic effect by blocking one or more targets of the signal transduction pathway, by increasing the bioavailability of the other drug or, by stabilizing the other drug in the system. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:239 / 249
页数:11
相关论文
共 112 条
[1]
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-i-induced signaling in an autochthonous mouse model of prostate cancer [J].
Adhami, VM ;
Siddiqui, IA ;
Ahmad, N ;
Gupta, S ;
Mukhtar, H .
CANCER RESEARCH, 2004, 64 (23) :8715-8722
[2]
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[3]
Airley R, 2001, CLIN CANCER RES, V7, P928
[4]
PHARMACOLOGY OF CURCUMA-LONGA [J].
AMMON, HPT ;
WAHL, MA .
PLANTA MEDICA, 1991, 57 (01) :1-7
[5]
[Anonymous], INTRO MEDICINAL CHEM
[6]
Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells [J].
Anuchapreeda, S ;
Leechanachai, P ;
Smith, MM ;
Ambudkar, SV ;
Limtrakul, P .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (04) :573-582
[7]
Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues [J].
Ashikawa, K ;
Shishodia, S ;
Fokt, L ;
Priebe, W ;
Aggarwal, BB .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (02) :353-364
[8]
IκB-NF-κB structures:: At the interface of inflammation control [J].
Baeuerle, PA .
CELL, 1998, 95 (06) :729-731
[9]
Drug interactions with the taxanes: clinical implications [J].
Baker, AF ;
Dorr, RT .
CANCER TREATMENT REVIEWS, 2001, 27 (04) :221-233
[10]
The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6